My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 177

    1.

    Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.

    Candelario-Jalil E, Mhadu NH, González-Falcón A, García-Cabrera M, Muñoz E, León OS, Fiebich BL.

    J Neuroinflammation. 2005 Jan 18;2(1):3.PMID: 15656909 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.

    Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL.

    Brain Res. 2004 May 8;1007(1-2):98-108.PMID: 15064140 [PubMed - indexed for MEDLINE]Related articles

    3.

    Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.

    Sayeed I, Wali B, Stein DG.

    Restor Neurol Neurosci. 2007;25(2):151-9.PMID: 17726274 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats.

    González-Falcón A, Candelario-Jalil E, García-Cabrera M, León OS.

    Brain Res. 2003 Nov 14;990(1-2):1-7.PMID: 14568323 [PubMed - indexed for MEDLINE]Related articles

    5.

    Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.

    Liu Y, Belayev L, Zhao W, Busto R, Belayev A, Ginsberg MD.

    Eur J Pharmacol. 2001 Oct 5;428(2):193-201.PMID: 11675036 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.

    Ishrat T, Sayeed I, Atif F, Stein DG.

    Brain Res. 2009 Feb 27;1257:94-101. Epub 2008 Dec 29.PMID: 19135987 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.

    Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM.

    J Pharmacol Exp Ther. 2007 Jun;321(3):892-901. Epub 2007 Mar 19.PMID: 17371805 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.

    Smith SE, Hodges H, Sowinski P, Man CM, Leach MJ, Sinden JD, Gray JA, Meldrum BS.

    Neuroscience. 1997 Apr;77(4):1123-35.PMID: 9130792 [PubMed - indexed for MEDLINE]Related articles

    9.

    Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.

    Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B.

    Stroke. 1999 Dec;30(12):2704-12; discussion 2712.PMID: 10583001 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

    Exp Neurol. 2008 Jul;212(1):53-62. Epub 2008 Mar 25.PMID: 18462720 [PubMed - indexed for MEDLINE]Related articles

    11.

    Detrimental effects of tropisetron on permanent ischemic stroke in the rat.

    Candelario-Jalil E, Muñoz E, Fiebich BL.

    BMC Neurosci. 2008 Feb 6;9:19.PMID: 18254974 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.

    Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH.

    Pharmacology. 2005 Jan;73(1):31-40. Epub 2004 Sep 27.PMID: 15452361 [PubMed - indexed for MEDLINE]Related articles

    13.

    High-dose methylprednisolone treatment in experimental focal cerebral ischemia.

    Slivka AP, Murphy EJ.

    Exp Neurol. 2001 Jan;167(1):166-72.PMID: 11161604 [PubMed - indexed for MEDLINE]Related articles

    14.

    Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.

    Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.

    Brain Res. 2009 May 19;1271:121-7. Epub 2009 Mar 28.PMID: 19332033 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.

    Sun HS, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, Ryan CL, Bernard PB, Lau A, Forder JP, Salter MW, Wang YT, Tasker RA, Tymianski M.

    Stroke. 2008 Sep;39(9):2544-53. Epub 2008 Jul 10.PMID: 18617669 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.

    Liang S, Pong K, Gonzales C, Chen Y, Ling HP, Mark RJ, Boschelli F, Boschelli DH, Ye F, Barrios Sosa AC, Mansour TS, Frost P, Wood A, Pangalos MN, Zaleska MM.

    J Pharmacol Exp Ther. 2009 Dec;331(3):827-35. Epub 2009 Sep 9.PMID: 19741150 [PubMed - indexed for MEDLINE]Related articles

    17.

    Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats.

    Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL.

    J Neurochem. 2007 Feb;100(4):1108-20. Epub 2006 Dec 20.PMID: 17176264 [PubMed - indexed for MEDLINE]Related articles

    18.

    Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia.

    Han R, Gao B, Sheng R, Zhang LS, Zhang HL, Gu ZL, Qin ZH.

    Acta Pharmacol Sin. 2008 Oct;29(10):1141-9.PMID: 18817617 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats.

    Roof RL, Schielke GP, Ren X, Hall ED.

    Stroke. 2001 Nov;32(11):2648-57.PMID: 11692030 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.

    Gupta YK, Chaudhary G, Sinha K.

    Can J Physiol Pharmacol. 2002 Mar;80(3):210-7.PMID: 11991232 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk